We are live on ! Find out more
Natixis Advisors

Natixis Advisors Portfolio holdings

AUM $71.9B
1-Year Est. Return 28.03%
This Fund
S&P 500
This Quarter Est. Return
+6.18%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$9.82B
AUM Growth
+$352M
Cap. Flow
-$145M
Cap. Flow %
-1.48%
Top 10 Hldgs %
15.24%
Holding
1,082
New
54
Increased
486
Reduced
487
Closed
55

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$11.7M
2
PYPL icon
PayPal
PYPL
+$9.54M
3
CELG
Celgene Corp
CELG
+$8.71M
4
MRK icon
Merck
MRK
+$8.25M
5
VTV icon
Vanguard Value ETF
VTV
+$8.01M

Sector Composition

Rank Sector Weight
1 Financials 16.69%
2 Technology 14.7%
3 Healthcare 11.28%
4 Industrials 9.7%
5 Consumer Discretionary 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETN icon
101
Eaton
ETN
$157B
$20.2M 0.21%
255,943
+21,599
+9% +$1.68M
BP icon
102
BP
BP
$113B
$20.1M 0.2%
521,304
+5,642
+1% +$204K
MET icon
103
MetLife
MET
$61B
$20M 0.2%
394,784
+5,904
+2% +$311K
UN
104
DELISTED
Unilever NV New York Registry Shares
UN
$19.8M 0.2%
352,272
-69,727
-17% -$4.02M
OXY icon
105
Occidental Petroleum
OXY
$57B
$19.6M 0.2%
266,581
-52,537
-16% -$3.57M
RDS.B
106
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$19.6M 0.2%
286,461
-9,167
-3% -$594K
SPY icon
107
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$19.1M 0.19%
71,554
+6,178
+9% +$1.61M
CLB icon
108
Core Laboratories
CLB
$538M
$18.9M 0.19%
172,727
+25,509
+17% +$2.55M
RIO icon
109
Rio Tinto
RIO
$148B
$18.8M 0.19%
355,787
+15,953
+5% +$779K
AZN icon
110
AstraZeneca
AZN
$263B
$18.8M 0.19%
271,220
+13,586
+5% +$916K
TJX icon
111
TJX Companies
TJX
$170B
$18.6M 0.19%
487,066
+41,790
+9% +$1.52M
TRV icon
112
Travelers Companies
TRV
$80.8B
$18.4M 0.19%
135,926
+722
+0.5% +$95.3K
APC
113
DELISTED
Anadarko Petroleum
APC
$18.3M 0.19%
340,503
+43,670
+15% +$2.15M
XOM icon
114
ExxonMobil
XOM
$651B
$18.3M 0.19%
218,283
+20,659
+10% +$1.71M
JCI icon
115
Johnson Controls International
JCI
$87.5B
$18.2M 0.19%
477,870
-86,538
-15% -$3.38M
FIS icon
116
Fidelity National Information Services
FIS
$21.5B
$17.9M 0.18%
190,254
-1,289
-0.7% -$121K
ABT icon
117
Abbott
ABT
$180B
$17.9M 0.18%
313,588
-111,236
-26% -$6.16M
MCK icon
118
McKesson
MCK
$98.5B
$17.9M 0.18%
114,548
+26,121
+30% +$3.87M
GM icon
119
General Motors
GM
$74.7B
$17.8M 0.18%
434,722
-24,711
-5% -$1.07M
CVS icon
120
CVS Health
CVS
$137B
$17.8M 0.18%
245,623
-95,346
-28% -$6.93M
CELG
121
DELISTED
Celgene Corp
CELG
$17.8M 0.18%
170,115
-77,196
-31% -$8.71M
HDB icon
122
HDFC Bank
HDB
$119B
$17.7M 0.18%
695,500
-29,684
-4% -$711K
AIG icon
123
American International
AIG
$41.9B
$17.6M 0.18%
295,129
+38,963
+15% +$2.39M
EW icon
124
Edwards Lifesciences
EW
$47.6B
$17.6M 0.18%
467,979
+94,062
+25% +$3.45M
MO icon
125
Altria Group
MO
$122B
$17.3M 0.18%
242,163
+50,408
+26% +$3.38M

Similar funds

Natixis Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Natixis Advisors held 1,082 positions worth $9.82B, up 3.7% from $9.47B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Natixis Advisors's Q4 2017 filing shows 54 new, 486 increased, 487 reduced and 55 closed positions. Its largest new stake was iShares MBS ETF: 135,380 shares worth $14.4M. The largest sale was Alibaba, an estimated $11.7M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Natixis Advisors's largest Q4 2017 buy was iShares MBS ETF: 135,380 shares worth $14.4M.
  • Natixis Advisors added most to Oracle in Q4 2017, an estimated $17.1M increase.
  • Natixis Advisors's biggest Q4 2017 reduction was Alibaba, cutting an estimated $11.7M.
  • Natixis Advisors fully exited Whirlpool in Q4 2017, selling an estimated $6.5M.
  • Natixis Advisors's ten largest holdings make up 15% of its $9.82B portfolio in Q4 2017.
  • Natixis Advisors opened 54 new positions and closed 55 in Q4 2017.
  • Natixis Advisors's portfolio value rose 3.7% quarter-over-quarter to $9.82B.

Based on Natixis Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.